Newsfeeds Archive - Spark Newswire

2 minute read

News

ProPhase Labs Unveils Project ZenQ-AI; Leveraging ProPhase Labs’ AI Platform, Massive Genomics Database And Patented Esophageal Cancer Insights For Antibody Drug Conjugates Development

April 16, 8:15 AM

Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs,

PRPH

3 minute read

ProPhase Labs Seeks To Transform Esophageal Cancer Detection And Management With Launch Of Its BE-Smart Test In H2 2024

By Benzinga Newsdesk

April 10, 8:09 AM

ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and diagnostics company, today reported its progress on the commercialization of its breakthrough BE-Smart test for

PRPH

3 minute read

ProPhase Labs Announces Progress In BE-Smart Esophageal Cancer Test Development USPTO Grants Additional Broad Patents For BE-SMART

By Happy Mohamed

February 20, 9:19 AM

ProPhase Labs, Inc. (NASDAQ:PRPH), a next generation biotech, genomics and diagnostics company, today announced important developments in the Company's efforts to commercialize its novel

PRPH

2 minute read

ProPhase Labs Announces Progress At Pharmaloz Manufacturing Accelerating Expansion, Improves Pricing, Boosts Profitability And Secures New Contracts

By Benzinga Newsdesk

January 23, 9:19 AM

Pharmaloz Wins Two New Contracts in January that are Anticipated to Significantly Increase Lozenge Revenues and ProfitabilityCompany in Late-Stage Discussions with Two Additional Large Global Brands Which, if

PRPH

2 minute read

Prophase Poised To Ramp Up Growth At Pharmaloz And Nebula Genomics In 2024; Company Announces The Hiring Of Long-Time Industry Veteran Jed Latkin As COO To Help Build And Manage This Growth

By Benzinga Newsdesk

January 4, 9:14 AM

Company also plans to commercialize its BE-Smart Esophageal Cancer Test in 2024Company announces the hiring of long-time industry veteran Jed Latkin as COO to help build and manage this growthGarden City, NY, Jan. 04,

PRPH

22 minute read

Earnings

Earnings Scheduled For November 9, 2023

By Benzinga Insights

November 9, 7:52 AM

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

AAOI

1 minute read

Earnings

ProPhase Labs Earnings Preview

By Benzinga Insights

November 8, 1:01 PM

ProPhase Labs (NASDAQ:PRPH) is set to give its latest quarterly earnings report on Thursday, 2023-11-09. Here’s what investors…

PRPH

3 minute read

DSS Inc. Issues Letter To Shareholders Providing An Update On Progress So Far This Year And Expectations Going Into The End Of The Year

By Happy Mohamed

October 12, 8:28 AM

DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that it has issued a Letter to Shareholders. Dear Valued Shareholders,

DSS